title: ADAMTSL3/punctin-2, a gene frequently mutated in colorectal tumors, is widely expressed in normal and malignant epithelial cells, vascular endothelial cells and other cell types, and its mRNA is reduced in colon cancer.
abstract: ADAMTSL3/punctin-2 is a secreted glycoprotein that resembles the ADAMTS proteases. Recently, identification of frequent ADAMTSL3 mutations in colorectal cancer suggested it might have a regulatory role in cellular homeostasis in colorectal epithelium or in pathways to colorectal malignancy. Here, we used in situ hybridization to validate ADAMTSL3 antibodies for IHC of a variety of normal and malignant tissues, including colon cancer. Quantitative real-time PCR (RTQ-PCR) was used to compare mRNA expression levels in colon carcinoma (n = 10) and adjacent normal colon. ADAMTSL3 is expressed in epithelial cells of the colon, fallopian tube, skin, breast, prostate, epididymis, liver, pancreatic islets and bile ducts, as well as by vascular endothelial cells, smooth muscle cells, fibroblasts, cortical and ganglionic neurons and cardiac myocytes. Malignant epithelial cells in colon cancer, as well as breast, prostate, renal and skin tumors expressed ADAMTSL3. Normal colon showed stronger immunostaining of surface than basal crypt epithelium and staining of a variety of cells within the lamina propria and submucosa. Colon carcinomas demonstrated weaker staining in tumor cells than normal colon epithelium and weak stromal staining. RTQ-PCR comparison of ADAMTSL3 mRNA in colon carcinoma and adjacent normal colon demonstrated a statistically significant reduction in the tumors, possibly reflecting their decreased stromal content and lack of complete differentiation of tumor samples. The major findings of these studies are that ADAMTSL3 is expressed in numerous tissues, suggesting a broader regulatory role than in colorectal epithelium alone, and that colorectal cancer has both structural mutations as well as decreased expression of ADAMTSL3.
authors.affiliation: Department of Biomedical Engineering, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.
authors.forename: Bon-Hun
authors.initials: BH
authors.lastname: Koo
authors.forename: Tiina
authors.initials: T
authors.lastname: Hurskainen
authors.forename: Katrina
authors.initials: K
authors.lastname: Mielke
authors.forename: Phyu Phyu
authors.initials: PP
authors.lastname: Aung
authors.forename: Graham
authors.initials: G
authors.lastname: Casey
authors.forename: Helena
authors.initials: H
authors.lastname: Autio-Harmainen
authors.forename: Suneel S
authors.initials: SS
authors.lastname: Apte
mesh_terms: D000071096:ADAMTS Proteins; D000911:Antibodies, Monoclonal; D015179:Colorectal Neoplasms / Q000737:chemistry* / Q000235:genetics*; D042783:Endothelial Cells / Q000737:chemistry*; D004847:Epithelial Cells / Q000737:chemistry*; D016326:Extracellular Matrix Proteins / Q000032:analysis* / Q000235:genetics*; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007150:Immunohistochemistry; D017403:In Situ Hybridization; D008297:Male; D009154:Mutation; D016133:Polymerase Chain Reaction; D012333:RNA, Messenger / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D046509:Tissue Culture Techniques
chemical_list: C491337:ADAMTSL3 protein, human; D000911:Antibodies, Monoclonal; D016326:Extracellular Matrix Proteins; D012333:RNA, Messenger; D000071096:ADAMTS Proteins